Development of Cancer Chemopreventive Agents: Oltipraz as a Paradigm-Reference-Cited by-同舟云学术

Development of Cancer Chemopreventive Agents: Oltipraz as a Paradigm

Published:1999-01-20 Issue:2 Volume:12 Page:113-126
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Kensler Thomas W.¹,Groopman John D.¹,Sutter Thomas R.¹,Curphey Thomas J.¹,Roebuck Bill D.¹

Affiliation:

1. Department of Environmental Health Sciences, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 21205, and Department of Pathology and Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03755

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx980185b

Reference114 articles.

1. Cancer Undefeated

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer chemoprevention;Medicinal Chemistry of Anticancer Drugs;2023

2. Rapid and selective generation of H2S within mitochondria protects against cardiac ischemia-reperfusion injury;Redox Biology;2022-09

3. The ameliorative effects of Nigella sativa, thymoquinone, and bentonite against aflatoxicosis in broilers via AFAR and Nrf2 signalling pathways, and down-regulation of caspase-3;British Poultry Science;2021-12-06

4. Preserving transcriptional stress responses as an anti‐aging strategy;Aging Cell;2021-01-20

5. Activation of Nrf2 signaling by oltipraz inhibits death of human macrophages with mycobacterium tuberculosis infection;Biochemical and Biophysical Research Communications;2020-10